Cargando…
Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer’s disease
There are currently no disease-modifying treatments for Alzheimer’s disease (AD), and an understanding of preclinical causal biomarkers to help target disease pathogenesis in the earliest phases remains elusive. Here, we investigated whether 19 metabolites previously associated with midlife cognitio...
Autores principales: | Lord, Jodie, Jermy, Bradley, Green, Rebecca, Wong, Andrew, Xu, Jin, Legido-Quigley, Cristina, Dobson, Richard, Richards, Marcus, Proitsi, Petroula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072203/ https://www.ncbi.nlm.nih.gov/pubmed/33879569 http://dx.doi.org/10.1073/pnas.2009808118 |
Ejemplares similares
-
Disentangling Independent and Mediated Causal Relationships Between Blood Metabolites, Cognitive Factors, and Alzheimer’s Disease
por: Lord, Jodie, et al.
Publicado: (2021) -
Metabolic correlates of late midlife cognitive outcomes: findings from the 1946 British Birth Cohort
por: Green, Rebecca, et al.
Publicado: (2021) -
Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease
por: Handy, Alex, et al.
Publicado: (2021) -
Lifetime cognition and late midlife blood metabolites: findings from a British birth cohort
por: Proitsi, Petroula, et al.
Publicado: (2018) -
Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease
por: Xu, Jin, et al.
Publicado: (2020)